Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells

Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells

The reactivation of human cytomegalovirus (HCMV) poses a serious health threat to immune compromised individuals. As a treatment strategy, dendritic cell (DC) vaccination trials are ongoing. Recent work suggests that BDCA-3+ (CD141+) subset DCs may be particularly effective in DC vaccination trials....

Descripció completa

Dades bibliogràfiques
Autors principals:	Flinsenberg, T, Compeer, E, Koning, D, Klein, M, Amelung, F, Van Baarle, D, Boelens, J, Boes, M
Format:	Journal article
Idioma:	English
Publicat:	American Society of Hematology 2012

Ítems similars

Antigen cross‐presentation: extending recent laboratory findings to therapeutic intervention
per: Flinsenberg, T, et al.
Publicat: (2011)

Tubulation of endosomal structures in human dendritic cells by Toll-like receptor ligation and lymphocyte contact accompanies antigen cross-presentation
per: Compeer, E, et al.
Publicat: (2013)

Anti‐BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc‐dependent and Fc‐independent mechanisms
per: Alex Pellerin, et al.
Publicat: (2015-03-01)

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
per: Laurissa Ouaguia, et al.
Publicat: (2019-02-01)

Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells.
per: Meera R Gupta, et al.
Publicat: (2014-01-01)

Enterovirus-infected β-cells induce distinct response patterns in BDCA1+ and BDCA3+ human dendritic cells.
per: Barbara M Schulte, et al.
Publicat: (2015-01-01)

Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation.
per: Ewoud Bernardus Compeer, et al.
Publicat: (2012-03-01)

Application of antigen cross-presentation research into patient care
per: Thijs eFlinsenberg, et al.
Publicat: (2014-06-01)

Differential susceptibility and response of primary human myeloid BDCA1(+) dendritic cells to infection with different Enteroviruses.
per: Barbara M Schulte, et al.
Publicat: (2013-01-01)

The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria.
per: Urban, B, et al.
Publicat: (2006)

The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function.
per: Evelyn van der Aa, et al.
Publicat: (2016-01-01)

MICAL-L1-related and unrelated mechanisms underlying elongated tubular endosomal network (ETEN) in human dendritic cells
per: Compeer, E, et al.
Publicat: (2014)

TLR3 signaling promotes the induction of unique human BDCA3 dendritic cell populations
per: Nicholas eColletti, et al.
Publicat: (2016-03-01)

Accumulation of BDCA1⁺ dendritic cells in interstitial fibrotic lung diseases and Th2-high asthma.
per: Alexandra M Greer, et al.
Publicat: (2014-01-01)

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.
per: Poulin, L, et al.
Publicat: (2010)

Antigen-Specific IgG ameliorates allergic airway inflammation via Fcγ receptor IIB on dendritic cells
per: Karasuyama Hajime, et al.
Publicat: (2011-04-01)

FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines
per: Christophe Macri, et al.
Publicat: (2024-04-01)

Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma
per: Bart Neyns, et al.
Publicat: (2024-01-01)

694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in solid tumors
per: Bart Neyns, et al.
Publicat: (2023-11-01)

Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
per: Bart Neyns, et al.
Publicat: (2022-09-01)

Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
per: Strieter Robert, et al.
Publicat: (2003-11-01)

Follicular Dendritic Cells Modulate Germinal Center B Cell Diversity through FcγRIIB
per: Cees E. van der Poel, et al.
Publicat: (2019-11-01)

Factor VIII Fc Fusion Protein but not FVIII Drives Human Monocyte-Derived Dendritic Cell Activation via FcγRIIa
per: Christoph Kannicht, et al.
Publicat: (2020-02-01)

Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation
per: Chen, Y, et al.
Publicat: (2019)

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2
per: Bruce D. Wines, et al.
Publicat: (2021-10-01)

The role of FcRn in antigen presentation
per: Kristi eBaker, et al.
Publicat: (2014-08-01)

FcεRI γ-Chain Negatively Modulates Dectin-1 Responses in Dendritic Cells
per: Yi-Gen Pan, et al.
Publicat: (2017-10-01)

Antibody Fc-receptor FcεR1γ stabilizes cell surface receptors in group 3 innate lymphoid cells and promotes anti-infection immunity
per: Chao Huang, et al.
Publicat: (2024-07-01)

Antigen Presenting Cells and Antigen Presentation in Tertiary Lymphoid Organs
per: Catherine Hughes, et al.
Publicat: (2016-11-01)

Enhancing antigen cross-presentation in human monocyte-derived dendritic cells by recruiting the intracellular Fc receptor TRIM21
per: Ng, Patricia M. L., et al.
Publicat: (2019)

The Diverse Functions of the Ubiquitous Fcγ Receptors and Their Unique Constituent, FcRγ Subunit
per: Thamer A. Hamdan, et al.
Publicat: (2020-02-01)

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?
per: Thomas J. van Ee, et al.
Publicat: (2018-09-01)

FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
per: Vijayashree Mysore, et al.
Publicat: (2021-08-01)

The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1
per: Jessica C. Anania, et al.
Publicat: (2018-08-01)

FcγRIIa and FcγRIIIa genes polymorphism in Egyptian children with primary immune thrombocytopenia
per: Marwa Zakaria, et al.
Publicat: (2023-01-01)

Fc γ receptor IIIB (FcγRIIIB) polymorphisms are associated with clinical malaria in Ghanaian children.
per: Bright Adu, et al.
Publicat: (2012-01-01)

Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc
per: Osman Dadas, et al.
Publicat: (2023-10-01)

Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.
per: Manuela Mandl, et al.
Publicat: (2015-01-01)

Antigen-specific memory T cell distribution in non-lymphoid tissue
per: Olurinde, Mobolaji O
Publicat: (2008)

Herpes Simplex Virus γ34.5 Interferes with Autophagosome Maturation and Antigen Presentation in Dendritic Cells
per: Philipe A. M. Gobeil, et al.
Publicat: (2012-11-01)